Pharmaceutical corporations need to stop free-riding on publicly-funded research | TheHill

Pharmaceutical corporations need to stop free-riding on publicly-funded research | TheHill: "The White House’s report suggests that it costs an estimated $2.6 billion to develop a new drug today, though they’re basing this on a single, non-transparent pharmaceutical industry-supported study with problematic methodology.

In reality, companies receive substantial publicly-funded support from the government. A recent study found that all 210 drugs approved in the U.S. between 2010 and 2016 benefitted from publicly-funded research, either directly or indirectly.

Taxpayers contribute through public university research, grants, subsidies, and other incentives. This means people are often paying twice for their medicines: through their tax dollars and at the pharmacy.

At Doctors Without Borders/Médecins Sans Frontières (MSF), we see each and every day the human suffering caused in the places we work and many countries outside the U.S. by treatments being rationed or people being denied essential medical care due to high drug and vaccines prices."



'via Blog this'

Sphere: Related Content